Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders

References

• Charoenputtakhun P, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2014. All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier. Pharm Dev Technol. 19:164–172.
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Du D, Liu W, Liu J, Weng T, et al. 2006. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 110:296–306.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, Kim S, Tan RBH. 2011. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces. 88:483–489.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–151.
   PubMed Web of Science ®Google Scholar
• Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, Rahimi AA. 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm. 424:128–37.
   PubMed Web of Science ®Google Scholar
• Gupta M, Tiwari S, Vyas SP. 2013. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Technol. 18:550–559.
   PubMed Web of Science ®Google Scholar
• Gupta V, Trivedi P. 2014. Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies. Artif Cells Nanomed Biotechnol. Early Online: 1–10, doi:https://doi.org/10.3109/21691401.2014.893523.
   Google Scholar
• Hao J, Wang F, Wang X, Zhang D, Bi Y, Gao Y, et al. 2012. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci. 47:497–505.
   PubMed Web of Science ®Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 401:93–102.
   PubMed Web of Science ®Google Scholar
• Khurana S, Bedi PMS, Jain NK. 2013a. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chem Phy Lipids. 175:65–72.
   PubMed Web of Science ®Google Scholar
• Khurana S, Jain NK, Bedi PMS. 2013b. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam Life Sci. 93: 763–772.
   Google Scholar
• Lason E, Sikora E, Ogonowski J. 2013. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation. Acta Biochemica Polonica. 60:773–777.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. 2007. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 328:191–195.
   PubMed Web of Science ®Google Scholar
• Liu M, Dong J, Yang Y, Yang X, Xu H. 2005. Characterization and release of triptolide-loaded poly (d, l-lactic acid) nanoparticles. Eur Polym J. 41:375–382.
   Web of Science ®Google Scholar
• Liu W, Hu M, Liu W, Xu CB, Xu H, Yang XL. 2008. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm. 364:135–141.
   PubMed Web of Science ®Google Scholar
• Lopes LB, Ferreira DA, Paula D, Garcia MJ, Thomazini JA, Fantini MA, Bentley MB. 2006. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of Cyclosporin A. Pharm Res. 23: 1332–1342.
   PubMed Web of Science ®Google Scholar
• Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. 2011. Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int J Pharm. 414:267–275.
   PubMed Web of Science ®Google Scholar
• Mulla JS, Khazi IM. 2009. Influence of process variables on particle size of solid lipid nanoparticles. Ind J Novel Drug Deliv. 1:47–49.
   Google Scholar
• Patil GB, Patil ND, Deshmukh PK, Patil PO, Bari SB. 2014. Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: application of factorial design approach. Artif Cells Nanomed Biotechnol. Early online, doi:https://doi.org/10.3109/21691401.2014.909820.
   Google Scholar
• Pouton CW. 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 29: 278–287.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. 2013. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 170: 380–395.
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. 2011. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 63:470–491.
   PubMed Web of Science ®Google Scholar
• Rawat M, Saraf S, Saraf S. 2007. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS Pharm Sci Tech. 4:289–297.
   Google Scholar
• Samein LH. 2014. Preparation and evaluation of nystatin loaded- solid-lipid nanoparticles for topical delivery. Int J Pharm Pharm Sci. 6:592–597.
   Google Scholar
• Schafer-Korting M, Mehnert W, Korting HC. 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 59:427–443.
   PubMed Web of Science ®Google Scholar
• Singh D, Dubey P, Pradhan M, Singh MR. 2013. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin Drug Deliv. 10:241–259.
   PubMed Web of Science ®Google Scholar
• Singh D, Nag M, Pradhan M, Singh MR. 2014. Vesicular system: versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol. Early Online, doi:https://doi.org/10.3109/21691401.2014.883401.
   Web of Science ®Google Scholar
• Singh M, Singh D, Saraf S. 2011. Influence of selected formulation variables on the preparation of peptide loaded lipospheres. Trends Med Res 6:863–876.
   Google Scholar
• Singh MR, Pradhan K, Singh D. 2012. Lipid Matrix Systems with emphasis on lipid microspheres: Potent Carriers for Transcutaneous Delivery of Bioactives. Curr Drug Deliv. 9:243–254.
   PubMed Web of Science ®Google Scholar
• Subedi RK, Kang KW, Choi H. 2009. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 37:508–513.
   PubMed Web of Science ®Google Scholar
• Trotta M, Gallarate M, Pattarino F, Morel S. 2001. Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. J Control Release. 76:119–128.
   PubMed Web of Science ®Google Scholar
• Uner M, Karaman EF, Aydoğmuş Z. 2014. Solid lipid nanoparticles and nanostructured lipid carriers of loratadine for topical application: physicochemical stability and drug penetration through rat skin. Tropical J Pharm Res. 13:653–660.
   Web of Science ®Google Scholar
• Vitorino C, Carvalho FA, Almeida AJ, Sousa JJ, Pais AA. 2011. The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces. 84:117–130.
   PubMed Web of Science ®Google Scholar